---
---

# 21 U.S.C., USLM ref /us/usc/t21/s360bbb–8b

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–8a.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–8c.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938b)

## § 360bbb–8b. Use of clinical investigation data from outside the United States

    (a) __In general__ 

        In determining whether to approve, license, or clear a drug or device pursuant to an application submitted under this subchapter, the Secretary shall accept data from clinical investigations conducted outside of the United States, including the European Union, if the applicant demonstrates that such data are adequate under applicable standards to support approval, licensure, or clearance of the drug or device in the United States.

    (b) __Notice to sponsor__ 

        If the Secretary finds under subsection (a) that the data from clinical investigations conducted outside the United States, including in the European Union, are inadequate for the purpose of making a determination on approval, clearance, or licensure of a drug or device pursuant to an application submitted under this subchapter, the Secretary shall provide written notice to the sponsor of the application of such finding and include the rationale for such finding.

([June 25, 1938, ch. 675, § 569B][/us/act/1938-06-25/ch675/s569B], as added [Pub. L. 112–144, title XI, § 1123][/us/pl/112/144/s1123], July 9, 2012, [126 Stat. 1113][/us/stat/126/1113].)

----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–8a.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptE/m__us_usc_t21_s360bbb–8c.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360bbb%E2%80%938b)

----------
----------

[/us/act/1938-06-25/ch675/s569B]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1938-06-25%2Fch675%2Fs569B
[/us/pl/112/144/s1123]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F112%2F144%2Fs1123
[/us/stat/126/1113]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F126%2F1113


